Related Experiment Video
Updated: Mar 15, 2026
09:28
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
Published on: September 16, 2020
9.5K
AMD-like retinopathy associated with intravenous iron
Delu Song1, Levi N Kanu1, Yafeng Li1
1F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.
Experimental Eye Research
|August 28, 2016
Summary
Intravenous iron therapy may cause retinal damage, mimicking age-related macular degeneration (AMD). This study in mice and a human case suggest IV iron could induce or worsen AMD-like retinal degeneration.
Area of Science:
- Ophthalmology
- Toxicology
- Biochemistry
Background:
- Retinal iron accumulation is linked to age-related macular degeneration (AMD).
- Intravenous (IV) iron is used to treat iron deficiency anemia, but its retinal effects are unknown.
- Investigating IV iron's potential retinal toxicity is crucial.
Purpose of the Study:
- To determine if IV iron formulations cause retinal toxicity.
- To explore the link between IV iron administration and AMD-like pathology.
Main Methods:
- A mouse model was developed to study iron-induced retinal damage.
- Mice received IV iron-sucrose or a sucrose control.
- Iron levels, histology, and ultrastructure of retinal tissues were analyzed.
Main Results:
- IV iron increased iron levels in the retinal pigment epithelium (RPE) and choroid, not the neurosensory retina.
- Histological changes in treated mice included Bruch's membrane thickening, C3 deposition, and RPE abnormalities, resembling AMD.
- A patient case showed AMD hallmarks after IV iron therapy.
Conclusions:
- IV iron therapy may induce or exacerbate retinal degeneration with AMD-like features.
- High choroidal iron levels correlate with focal retinal degeneration.
- Further research is needed on AMD risk in patients undergoing IV iron treatment.
